Literature DB >> 11123076

Clinical trials for the treatment of systemic onset juvenile rheumatoid arthritis-juvenile idiopathic arthritis.

T J Lehman1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11123076     DOI： 10.1007/s11926-000-0068-9

Source DB:  PubMed          Journal:  Curr Rheumatol Rep        ISSN： 1523-3774            Impact factor:   4.592


× No keyword cloud information.
  8 in total

1.  Repetitive use of pulse therapy with methylprednisolone and cyclophosphamide in addition to oral methotrexate in children with systemic juvenile rheumatoid arthritis--preliminary results of a longterm study.

Authors:  A V Shaikov; A A Maximov; A I Speransky; D J Lovell; E H Giannini; S K Solovyev
Journal:  J Rheumatol       Date:  1992-04       Impact factor: 4.666

Review 2.  Systemic onset juvenile rheumatoid arthritis.

Authors:  R Schneider; R M Laxer
Journal:  Baillieres Clin Rheumatol       Date:  1998-05

3.  Intravenous immunoglobulin therapy in systemic onset juvenile rheumatoid arthritis: a followup study.

Authors:  Y Uziel; R M Laxer; R Schneider; E D Silverman
Journal:  J Rheumatol       Date:  1996-05       Impact factor: 4.666

4.  Suppression of fever and the acute-phase response in a patient with juvenile chronic arthritis treated with monoclonal antibody to tumour necrosis factor-alpha (cA2).

Authors:  M J Elliott; P Woo; P Charles; A Long-Fox; J N Woody; R N Maini
Journal:  Br J Rheumatol       Date:  1997-05

5.  Trial of intravenous pulse cyclophosphamide and methylprednisolone in the treatment of severe systemic-onset juvenile rheumatoid arthritis.

Authors:  C A Wallace; D D Sherry
Journal:  Arthritis Rheum       Date:  1997-10

6.  Autologous haemopoietic stem-cell transplantation in four patients with refractory juvenile chronic arthritis.

Authors:  N Wulffraat; A van Royen; M Bierings; J Vossen; W Kuis
Journal:  Lancet       Date:  1999-02-13       Impact factor: 79.321

7.  Intravenous immunoglobulin in the treatment of systemic juvenile rheumatoid arthritis: a randomized placebo controlled trial. Pediatric Rheumatology Collaborative Study Group.

Authors:  E D Silverman; G D Cawkwell; D J Lovell; R M Laxer; T J Lehman; M H Passo; L S Zemel; E H Giannini
Journal:  J Rheumatol       Date:  1994-12       Impact factor: 4.666

Review 8.  Cytokines in juvenile rheumatoid arthritis (JRA).

Authors:  H Mangge; K Schauenstein
Journal:  Cytokine       Date:  1998-06       Impact factor: 3.861
  8 in total
  2 in total

1.  Systemic arthritis in children: a review of clinical presentation and treatment.

Authors:  R Gurion; T J A Lehman; L N Moorthy
Journal:  Int J Inflam       Date:  2011-12-25

2.  Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade.

Authors:  Virginia Pascual; Florence Allantaz; Edsel Arce; Marilynn Punaro; Jacques Banchereau
Journal:  J Exp Med       Date:  2005-04-25       Impact factor: 14.307
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.